| |
| |
|
| Insider
Information: |
Hallal David |
| Relationship: |
Director |
| City: |
Cheshire |
| State: |
CT |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
5 |
|
| Direct
Shares |
2,885,473 |
|
|
Indirect Shares
|
17,647,006 |
|
|
| Direct
Value |
$39,805,633 |
|
|
|
Indirect Value
|
$34,240,539 |
|
|
| Total
Shares |
20,532,479 |
|
|
| Total
Value |
$74,046,172 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
3
|
|
Stock
price went up :
|
0
|
1
|
| Stock
price went down : |
0
|
2
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -113.4%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Alexion Pharmaceuticals Inc |
ALXN |
CEO, Director |
2016-08-08 |
189,266 |
2014-12-18 |
113,122 |
Premium* |
|
|
Scholar Rock Holding Corp |
SRRK |
Director |
2019-09-18 |
290,595 |
2019-09-18 |
0 |
Premium* |
|
|
Allovir Inc |
ALVR |
Director, 10% Owner |
2023-05-11 |
2,108,662 |
2023-05-11 |
17,533,884 |
Premium* |
|
|
Seer, Inc. |
SEER |
Director |
2023-06-14 |
296,950 |
|
0 |
Premium* |
|
|
Iteos Therapeutics, Inc. |
ITOS |
Director |
2022-06-09 |
0 |
2021-12-20 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
127 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 6
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2015-03-31 |
4 |
A |
$0.00 |
$0 |
D/D |
11,270 |
144,128 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2015-08-04 |
4 |
S |
$196.52 |
$120,270 |
D/D |
(612) |
143,516 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2015-08-07 |
4 |
S |
$190.01 |
$62,513 |
D/D |
(329) |
143,187 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2016-02-04 |
4 |
A |
$0.00 |
$0 |
D/D |
41,136 |
183,694 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2016-02-04 |
4 |
S |
$143.81 |
$90,469 |
D/D |
(629) |
142,558 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2016-02-05 |
4 |
S |
$140.49 |
$952,043 |
D/D |
(6,722) |
176,972 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2016-02-08 |
4 |
S |
$138.02 |
$544,763 |
D/D |
(3,946) |
173,026 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2016-02-26 |
4 |
A |
$0.00 |
$0 |
D/D |
20,000 |
193,026 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2016-02-29 |
4 |
S |
$138.91 |
$279,800 |
D/D |
(2,014) |
191,012 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2016-04-01 |
4 |
S |
$135.87 |
$192,132 |
D/D |
(1,414) |
189,598 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2016-08-08 |
4 |
S |
$137.14 |
$45,530 |
D/D |
(332) |
189,266 |
0 |
- |
|
| ALVR |
Allovir Inc |
Chief Executive Officer |
• • • |
2020-08-03 |
4 |
A |
$0.00 |
$0 |
I/I |
14,315,700 |
738,153 |
0 |
- |
|
| ALVR |
Allovir Inc |
Chief Executive Officer |
• • • |
2021-01-21 |
4 |
A |
$0.00 |
$0 |
D/D |
147,000 |
2,230,666 |
0 |
- |
|
| ALVR |
Allovir Inc |
Chief Executive OfficerOfficer |
• • • |
2020-07-29 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
2,083,666 |
|
- |
|
| ALVR |
Allovir Inc |
Chief Executive OfficerOfficer |
• • • |
2020-07-29 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
964,388 |
|
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Chief Operating Officer |
• • – |
2014-11-03 |
4 |
OE |
$17.65 |
$611,736 |
D/D |
30,000 |
148,616 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Chief Operating Officer |
• • – |
2014-11-03 |
4 |
S |
$190.00 |
$5,700,287 |
D/D |
(30,000) |
118,616 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Chief Operating Officer |
• • – |
2014-12-18 |
4 |
AS |
$182.03 |
$1,000,073 |
I/I |
(5,494) |
113,122 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Chief Operating Officer |
• • – |
2015-02-03 |
4 |
S |
$174.02 |
$133,125 |
D/D |
(765) |
117,851 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Chief Operating Officer |
• • – |
2015-02-04 |
4 |
S |
$174.38 |
$106,023 |
D/D |
(608) |
117,243 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Chief Operating Officer |
• • – |
2015-02-05 |
4 |
A |
$0.00 |
$0 |
D/D |
11,690 |
128,933 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Chief Operating Officer |
• • – |
2015-02-09 |
4 |
S |
$173.93 |
$507,876 |
D/D |
(2,920) |
126,013 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Chief Operating Officer |
• • – |
2015-02-10 |
4 |
S |
$171.15 |
$338,877 |
D/D |
(1,980) |
124,033 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Chief Operating Officer |
• • – |
2015-02-27 |
4 |
A |
$0.00 |
$0 |
D/D |
9,555 |
133,588 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Chief Operating Officer |
• • – |
2015-03-02 |
4 |
S |
$180.34 |
$131,648 |
D/D |
(730) |
132,858 |
0 |
- |
|
127 Records found
|
|
Page 1 of 6 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
